Search Results - "Gristina, V."

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies by Russo, A., Incorvaia, L., Del Re, M., Malapelle, U., Capoluongo, E., Gristina, V., Castiglia, M., Danesi, R., Fassan, M., Giuffrè, G., Gori, S., Marchetti, A., Normanno, N., Pinto, C., Rossi, G., Santini, D., Sartore-Bianchi, A., Silvestris, N., Tagliaferri, P., Troncone, G., Cinieri, S., Beretta, G.D.

“…The term liquid biopsy (LB) refers to the use of various biological fluids as a surrogate for neoplastic tissue to achieve information for diagnostic,…”
Get full text

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials by Galvano, A., Gristina, V., Malapelle, U., Pisapia, P., Pepe, F., Barraco, N., Castiglia, M., Perez, A., Rolfo, C., Troncone, G., Russo, A., Bazan, V.

“…The role of tumor mutational burden (TMB) is still debated for selecting advanced non-oncogene addicted non-small-cell lung cancer (NSCLC) patients who might…”
Get full text

Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) by Incorvaia, L, Badalamenti, G, Novo, G, Gori, S, Cortesi, L, Brando, C, Cinieri, S, Curigliano, G, Ricciardi, G R, Toss, A, Chiari, R, Berardi, R, Ballatore, Z, Bono, M, Bazan Russo, T D, Gristina, V, Galvano, A, Damerino, G, Blasi, L, Bazan, V, Russo, A

“…The BRCA proteins play a key role in the homologous recombination (HR) pathway. Beyond BRCA1/2, other genes are involved in the HR repair (HRR). Due to the…”
Get full text

1221P The functional domain of BRCA1/2 pathogenic variants (PVs) as potential biomarkers of second tumor and domain-related sensitivity to PARP-inhibitors by Incorvaia, L., Marchetti, C., Brando, C., Perez, A., Bono, M., Barraco, N., Cancelliere, D., Pivetti, A., Cardone, F., Bazan Russo, T.D., Castellana, L., Congedo, L., Piraino, P., Ergasti, R., Gristina, V., Galvano, A., Fanale, D., Bazan, V., Scambia, G., Russo, A.

Get full text

1094P The clinical potential of circulating-free DNA (cfDNA) for real-time longitudinally monitoring clinical outcomes in a real-world first-line non-small cell lung cancer (NSCLC) prospective study by Gristina, V., Barraco, N., Galvano, A., La Mantia, M., Cutaia, S., Iacono, F., Lisanti, C., Inguglia, S., Sardo, D., Perez, A., Cusenza, S., Castellana, L., Bazan Russo, T.D., Vieni, S., Fulfaro, F., Incorvaia, L., Badalamenti, G., Bazan, V., Russo, A.

Get full text

904MO Anthracycline-related cardiotoxicity in breast cancer patients carrying mutational signature of homologous recombination deficiency (HRD) by Incorvaia, L., Fiorino, A., Gori, S., Cinieri, S., Curigliano, G., Toss, A., Cortesi, L., Ricciardi, G.R.R., Chiari, R., Peri, M., Brando, C., Bazan Russo, T.D., Gristina, V., Galvano, A., Damerino, G., Carreca, I.U., Novo, G., Badalamenti, G., Bazan, V., Russo, A.

Get full text

P-173 Understanding the treatment algorithm of patients with advanced G2 gastroenteropancreatic neuroendocrine neoplasms: A single-institution retrospective analysis by Peri, M., Incorvaia, L., Spinnato, V., Corsini, L., Scalia, R., Dimino, A., Algeri, L., Schiacchitano, R., Magrin, L., Galvano, A., Gristina, V., Cusenza, S., Bazan, V., Badalamenti, G., Russo, A.

Get full text

P-264 The molecular-metabolic interplay in metastatic gastrointestinal stromal tumors (GISTs): The predictive role of body mass index by Incorvaia, L., Brando, C., Algeri, L., Dimino, A., Pedone, E., Schiacchitano, R., Magrin, L., Fiorino, A., Perez, A., Barraco, N., Bono, M., Cancelliere, D., Pivetti, A., Bazan Russo, T., Contino, S., Gristina, V., Galvano, A., Bazan, V., Russo, A., Badalamenti, G.

Get full text

1974P Improved risk stratification with a prognostic nomogram incorporating the KIT-Variant Allele Frequency (VAF) and the 557/558 deletions: Results from a multi-institutional study in a cohort of intermediate-risk GIST patients by Incorvaia, L., de Biase, D., Gottardo, A., Nannini, M., Brando, C., Fumagalli, E.R., Vincenzi, B., De Luca, I., Dimino, A., Pantaleo, M.A., Gasperoni, S., D'Ambrosio, L., Grignani, G., Algeri, L., Russo, T.D. Bazan, Gristina, V., Galvano, A., Bazan, V., Russo, A., Badalamenti, G.

Get full text

2001P Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy by Longo, V., Vitiello, F., Spinnato, F., Ambrosio, F., Del Giudice, T., Sergi, M.C.I., Casaluce, F., Montrone, M., Gilli, M., Reale, M.L., Di Liello, R., Russo, A., Sforza, V., Gristina, V., Servetto, A., Cristofano, A., Viscardi, G., Marchese, A., Galetta, D., Della Corte, C.M.

Get full text

1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study by Badalamenti, G., Incorvaia, L., Bonasera, A., Algeri, L., Dimino, A., Cucinella, A., Madonia, G., Scalia, R., Fanale, D., Li Pomi, F., Galvano, A., Gristina, V., Corsini, L.R., Brando, C., Bazan, V., Russo, A.

Get full text

1535P Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GISTs) by Incorvaia, L., Badalamenti, G., Fanale, D., Brando, C., Algeri, L., Dimino, A., Scalia, R., Barraco, N., Bono, M., Pedone, E., Cancelliere, D., Fiorino, A., Galvano, A., Gristina, V., Perez, A., Li Pomi, F., Corsini, L.R., Pivetti, A., Bazan, V., Russo, A.

Get full text

166P Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes by Bono, M., Fanale, D., Incorvaia, L., Barraco, N., Brando, C., Calò, V., Cancelliere, D., Corsini, L.R., Dimino, A., Filorizzo, C., Fiorino, A., Gristina, V., Magrin, L., Pedone, E., Perez, A., Pivetti, A., Scalia, R., Sciacchitano, R., Bazan, V., Russo, A.

Get full text

20P Is evaluation of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutational status on circulating tumour DNA (ctDNA) by liquid biopsy ready for prime-time? A systematic review and an individual patient meta-analysis by Castellana, L., Gristina, V., Galvano, A., La Mantia, M., Insalaco, L., Barraco, N., Cutaia, S., Iacono, F., Santanelli, G., Cucinella, A., Madonia, G., Ricciardi, M.R., Lisanti, M.C., Calò, V., Castiglia, M., Perez, A., Cusenza, S., Rizzo, S., Russo, A., Bazan, V.

Get full text

738P Soluble PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTN2A1 as predictive biomarkers of nivolumab response in patients with metastatic clear cell renal carcinoma by Incorvaia, L., Fanale, D., Badalamenti, G., Iovanna, J.L., Porta, C., Rizzo, M., Corsini, L., Brando, C., Bono, M., La Mantia, M., Olive, D., Gristina, V., Gri, N., Fiorino, A., Bazan, V., Russo, A.

Get full text

1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials by Gristina, V., Galvano, A., Barraco, N., Castellana, L., Insalaco, L., Guarini, A., Bono, M., Militi, G., Ricciardi, M., Cutaia, S., Cucinella, A., Madonia, G., Tomasello, L., Filorizzo, C., Fanale, D., Incorvaia, L., Rizzo, S., Badalamenti, G., Bazan, V., Russo, A.

Get full text

1818P Body mass index (BMI) is not a cancer risk factor for BRCA1/2 carriers: A systematic review and meta-analysis of case-control studies by Gristina, V., Galvano, A., Mirisola, M., La Mantia, M., Giaconia, M., Li Pomi, F., Barraco, N., Castiglia, M., Perez, A., Bono, M., Iacono, F., Cutaia, S., Lisanti, M.C., Insalaco, L., Castellana, L., Calò, V., Cusenza, S., Incorvaia, L., Russo, A., Bazan, V.

Get full text

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer by De Luca, Rossella, Blasi, Livio, Alù, Massimiliano, Gristina, Valerio, Cicero, Giuseppe

“…Pancreatic carcinoma is the neoplasia with the major mortality, and main standard treatments in this cancer increase survival but do not lead to complete…”
Get full text

LncRNA H19, HOTAIR and MALAT1 as prognostic molecular biomarkers in GIST by Barraco, N., Incorvaia, L., Badalamenti, G., Passiglia, F., Listì, A., Maragliano, R., Musso, E., Bronte, E., Cabibi, D., Calò, V., Castiglia, M., Fanale, D., Galvano, A., Gristina, V., Ingrao, S., Insalaco, L., Massihnia, D., Perez, A., Bazan, V., Russo, A.

Get full text

69P Trabectedin rechallenge for the treatment of adults with advanced soft tissue sarcoma (STS): A pilot study (Re-Trabe) by Badalamenti, G., Algeri, L., Dimino, A., Magrin, L., De Luca, I., Sciacchitano, R., Alimondi, F., Gennusa, V., Caiozzo, I., Bazan Russo, T.D., Galvano, A., Gristina, V., Bazan, V., Incorvaia, L., Russo, A.

Get full text